Chris Molloy on investment for BIA members; TIME’s Best Inventions; MHRA 2030 Strategy; Rare disease medicines review; Party conferences; TechBio; and BIA's AGM
Chris Molloy on investment in dementia; AI in healthcare; TechBio; BioJapan; bioProcessUK; Green, Conservative and Labour conferences; and BIA Board elections
Causeway Sensors and Fusion Antibodies share a case study on how TITAN’s real-time, at-line analytics detected key harvest yield differences by Day 3, enabling early process intervention and smarter resource allocation.
The UK’s innovative life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines.
BIA’s health data vision 2035 report sets out how the UK can use consented and well-governed health data to drive economic growth, innovation and better patient outcomes.
In this blog, Ethan Almond reflects on the inaugral BioSolutions UK conference, which brought together over 200 innovators, policymakers and industry leaders alongside an additional 29 investors.
The UK BioIndustry Association (BIA) is the UK’s trade association for innovative life sciences and the leading UK-wide forum for expert communities and high quality peer-to-peer networking in the sector.
The UK’s biosolutions sector has established itself as a billion-pound frontier industry, with companies raising £1.46 billion in equity investment since 2018.
Charlotte Cane, MP for Ely and East Cambridgeshire, visited local life science companies on 31 March to see for herself how new medicines and medical technologies are being developed.
There are a number of significant moving pieces right now in the sector, including the major strategic shift at UKRI and Innovate launched last Thursday.
In this guest blog, Dr David Montgomery, co-founder of PM Life Sciences, discusses the reality of UK-originated assets, companies and long-term economic returns ending up overseas despite record public investment and a world-class discovery base.
In this blog, Emily Klein reflects on the importance of Rare Disease Day in bringing visibility to those affected by a rare condition and serving as a focal point for advocacy in this space.
It’s been an energising week across the UK life sciences landscape, marked by major investment, important conversations and new opportunities for our community.
In this guest blog, Hareklea Markides, Innovation Lead - Medicines Manufacturing at Innovate UK, reflects on the UK BioIndustry Association's (BIA) annual #bioProcessUK conference.
TechBio’s potential to both transform our sector and provide precision diagnosis and care to patients is well recognised, and TechBio Boost is playing a vital role in scaling companies in this space.
